Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Green Thumb Industries Inc GTBIF


Primary Symbol: C.GTII

Green Thumb Industries Inc. is a cannabis consumer packaged goods company. It is a retailer, which promotes well-being through the power of cannabis while giving back to the communities in which it serves. It has two segments: Retail and Consumer Packaged Goods. The Company owns, manufactures and distributes a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomons, Good Green, incredibles and RYTHM, to third-party retail stores across the United States, as well as to its own retail stores. It also owns and operates retail cannabis stores that include a national chain called RISE Dispensaries, as well as retail stores operating under other names. Its retail stores sell a combination of its products and third-party products. It operates in 14 United States markets, including California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.


CSE:GTII - Post by User

Post by retiredcfon Dec 01, 2020 1:45pm
458 Views
Post# 32010650

Another Earnings Assessment

Another Earnings AssessmentGTII sales of $157M were 16% ahead of estimates; EPS of $0.045 was well ahead of the estimates of $0.012. EBITDA of $53M was also 37% higher than forecasted while revenue rose 131%. Cash flow was positive and the results show why the stock has done so well. Guidance was good despite the fact that most analysts view it as conservative. It was not surprising that GTII received multiple broker upgrades. 

This assessment was from 5iResearch who admittedly have never been big fans of the sector. That said, they view this as one of the few gems. GLTA
<< Previous
Bullboard Posts
Next >>